Darifenacin
Darifenacin | CAS NO: 133099-04-4, Darifenacin is a medication primarily used to treat conditions related to overactive bladder (OAB). Darifenacin is an antimuscarinic drug that works by blocking certain receptors in the bladder, reducing symptoms of overactive bladder.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Darifenacin impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities It helps relax the bladder muscles and increases the bladder's capacity, reducing the number of times a person feels the urge to urinate. This medication is typically prescribed for adults who experience these symptoms as a result of OAB. It's usually taken once daily in tablet form. Buy Reliable and High-Purity Darifenacin Impurities, Delivered by Synchemia Research Chemicals.
Pharmaceutical Reference Standards
| CAT No | SRC-D3221 |
| CAS No | 133099-07-7 |
| Mol.F. | C28H30N2O2 : HBr |
| Mol.Wt. | 426.6 : 80.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3222 |
| CAS No | NA |
| Mol.F. | C28H30N2O2 : HCl |
| Mol.Wt. | 426.6 : 36.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3223 |
| CAS No | 134002-26-9 |
| Mol.F. | C18H20N2O : C4H6O6 |
| Mol.Wt. | 280.4 : 150.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3224 |
| CAS No | 206048-82-0 |
| Mol.F. | C28H30N2O3 |
| Mol.Wt. | 442.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3225 |
| CAS No | 127264-14-6 |
| Mol.F. | C10H11BrO |
| Mol.Wt. | 227.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3226 |
| CAS No | 69999-16-2 |
| Mol.F. | C10H10O3 |
| Mol.Wt. | 178.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3227 |
| CAS No | 871505-23-6 |
| Mol.F. | C18H18N2 : HCl |
| Mol.Wt. | 262.4 : 36.5 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-D3228 |
| CAS No | 2280857-32-9 |
| Mol.F. | C38H40N2O3 |
| Mol.Wt. | 572.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3229 |
| CAS No | NA |
| Mol.F. | C28H28N2O : HCl |
| Mol.Wt. | 408.5 : 36.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3230 |
| CAS No | 133034-06-7 |
| Mol.F. | C10H9BrO |
| Mol.Wt. | 225.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3231 |
| CAS No | 1391080-43-5 |
| Mol.F. | C28H29BrN2O2 |
| Mol.Wt. | 505.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3232 |
| CAS No | 1598271-92-1 |
| Mol.F. | C10H11BrO |
| Mol.Wt. | 227.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3233 |
| CAS No | 1797983-04-0 |
| Mol.F. | C38H40N2O3 |
| Mol.Wt. | 572.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-D3234 |
| CAS No | 103887-32-7 |
| Mol.F. | C18H20N2O |
| Mol.Wt. | 280.4 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-D3235 |
| CAS No | 2468796-89-4 |
| Mol.F. | C28H31BrN2O2 |
| Mol.Wt. | 507.5 g/mol |
| INV STATUS | IN STOCK |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.